Cytokinetics (CYTK) PT Raised to $50 at BofA Securities
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.87 --0%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Cytokinetics (NASDAQ: CYTK) to $50.00 (from $49.00) while maintaining a Neutral rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Teijin Ltd (3401:JP) PT Raised to JPY1,860 at Nomura/Instinet
- JCR Pharmaceuticals Co Ltd (4552:JP) PT Raised to JPY540 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
